carbidopa has been researched along with Dysphagia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artusi, CA; Bianchini, E; De Carolis, L; Galli, S; Imbalzano, G; Ledda, C; Lopiano, L; Pontieri, FE; Rinaldi, D; Zibetti, M | 1 |
| Altiparmak, E; Erdoğan Küçükdağli, F; Köseoğlu, HT; Öztürk, Ö; Saltoğlu, T; Sücüllü Karadağ, Y | 1 |
| Apetauerova, D; Norregaard, T; Ryan, P; Tarsy, D | 1 |
| Cooper, SD; Frank, C; Ismail, HA | 1 |
4 other study(ies) available for carbidopa and Dysphagia
| Article | Year |
|---|---|
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.
Topics: Antiparkinson Agents; Carbidopa; Deglutition Disorders; Dementia; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Retrospective Studies | 2023 |
Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients
Topics: Abdomen, Acute; Aged; Carbidopa; Catheterization; Deglutition Disorders; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dysarthria; Dyskinesias; Endoscopy; Female; Gait; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome; Turkey | 2021 |
Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.
Topics: Antiparkinson Agents; Atrophy; Carbidopa; Combined Modality Therapy; Contraindications; Deglutition Disorders; Diagnosis, Differential; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Microelectrodes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Putamen; Subthalamic Nucleus | 2003 |
Case report: successful use of rectally administered levodopa-carbidopa.
Topics: Administration, Oral; Administration, Rectal; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Deglutition Disorders; Female; Humans; Levodopa; Parkinson Disease; Patient Compliance | 2001 |